Steve Casella
About Steve Casella
Steve Casella is the Vice President of Research & Development at BeiGene with over 25 years of experience in finance and research & development roles within the biotechnology and pharmaceutical industries.
Company
Steve Casella is currently employed at BeiGene as the Vice President of Research & Development in Emeryville, California, United States. BeiGene is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.
Title
Steve Casella holds the position of Vice President, Research & Development at BeiGene. He has been in this role since July 2020, contributing his extensive experience in finance and research & development to the company.
Education and Expertise
Steve Casella completed his undergraduate education at The University of Texas at Austin, earning a Bachelor of Arts (B.A.) in History from 1991 to 1995. He brings over 25 years of experience in finance and research & development roles within the biotechnology and pharmaceutical industries.
Career at Genentech and Roche
Steve Casella's career includes significant tenure at Genentech and Roche. From 2017 to 2020, he served as the Head of Finance, Late Stage Portfolio Committee at Genentech / Roche in the San Francisco Bay Area. Prior to that, he was the Finance & IT Director at Roche Hungary Kft from 2015 to 2017 and Director, Global Supply Chain Finance from 2012 to 2015. He also held the role of Director, Global Development Finance at Genentech from 2005 to 2012.
Previous Roles in Finance
Earlier in his career, Steve Casella worked at Kosan Biosciences as Director of Finance from 2001 to 2005 and at Arthur Andersen, LLP as Manager from 1996 to 2001. His roles have consistently focused on strategic and operational finance, with a notable emphasis on managing global supply chain finance operations and late-stage portfolio management.